If anti-Factor Xa levels rise above the expected therapeutic range (peak 1.0 to 4.0 ng/mL for apixaban 5 mg BID, per the FDA label), reduce or discontinue BPC-157 rather than adjusting the apixaban dose
Obesity, affected by both low and high birth weights, is a significant contributor to insulin resistance, dyslipidemia, and hyperinsulinemia, all of which are elements of metabolic syndrome
Haidar A, Tsoukas MA, Bernier-Twardy S, et al
To this purpose, the present review aims to discuss the advantages and challenges of using standard and cutting-edge techniques to discover salivary biomarkers which may be used in diagnosis/therapy of several chronic diseases with inflammatory consequences with the pursuit to possibly replace conventional paths with detectable soluble mediators in saliva